Key result
Intra-arterial urokinase resolves acute renal artery embolism complicating left accessory pathway ablation in HCM.
Why the study?
Hypertrophic cardiomyopathy carries an increased risk of thromboembolism, most commonly with atrial fibrillation, whereas systemic arterial embolism following left-sided radiofrequency ablation in patients without documented atrial fibrillation is rare.
Case Report (n=1)
No
This case highlights the risk of systemic arterial embolism following left-sided radiofrequency ablation in patients with hypertrophic cardiomyopathy, even in the absence of atrial fibrillation, and demonstrates successful management with intra-arterial thrombolysis.
Answers are grounded in this paper and cite their sources.
Warrants vigilance for renal embolism after left ablation in HCM without AF; leaves open need for prospective data on prevention.
Background Hypertrophic cardiomyopathy (HCM) is associated with arrhythmias and an increased risk of thromboembolism, most commonly in the presence of atrial fibrillation. Systemic arterial embolism following left-sided radiofrequency ablation (RFA) is rare. We report an unusual case of acute right renal artery embolism after RFA of a left lateral accessory pathway in a patient with long-standing nonobstructive HCM and no documented atrial fibrillation. Case presentation A 53-year-old man with a 10-year history of nonobstructive HCM presented with paroxysmal palpitations. Electrophysiological study confirmed atrioventricular reentrant tachycardia mediated by a left lateral accessory pathway, and successful RFA was performed via transseptal access. On postoperative day 2, he developed sudden right flank pain. Abdominal computed tomography and selective renal angiography demonstrated distal right renal artery embolism with partial renal infarction. Intra-arterial thrombolysis with urokinase (500,000 IU) achieved prompt reperfusion, and anticoagulation was continued. Continuous rhythm monitoring, transthoracic echocardiography, and cardiac magnetic resonance imaging revealed no atrial fibrillation or intracardiac thrombus. Discussion This case highlights a rare but clinically important thromboembolic complication following left-sided RFA in a patient with HCM without documented atrial fibrillation. The mechanism of embolization remains uncertain; however, potential contributors include procedure-related thrombus formation or embolic material associated with left-sided cardiac instrumentation, with underlying HCM-related structural abnormalities possibly representing an additional susceptibility factor. Early recognition of acute visceral embolization and timely endovascular reperfusion therapy were essential for preserving renal function and achieving a favorable clinical outcome. This case emphasizes the importance of considering systemic embolic complications after left-sided electrophysiological procedures in selected HCM patients, while the optimal peri-procedural antithrombotic strategy requires further investigation. Conclusion Clinicians should maintain a high index of suspicion for systemic embolism after left-sided electrophysiological procedures in HCM patients, even when atrial fibrillation is not present. Peri-procedural anticoagulation strategies and post-procedural monitoring warrant careful consideration and further study.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) conducted a case report in Nonobstructive hypertrophic cardiomyopathy and atrioventricular reentrant tachycardia (n=1). Radiofrequency ablation of a left lateral accessory pathway via transseptal access, followed by intra-arterial thrombolysis with urokinase was evaluated on Acute right renal artery embolism and subsequent reperfusion. Radiofrequency ablation of a left lateral accessory pathway in a 53-year-old man with HCM was complicated by acute right renal artery embolism on day 2, treated with 500,000 IU intra-arterial urokinase.
Synapse has enriched 10 related papers. Consider them for comparative context: